What the name describes
Small cell melanoma contains relatively small tumour cells within tissue. The name does not measure the diameter of the skin lesion or automatically mean early disease. Literature describes overlap with nevoid melanoma because the cells can resemble those of a benign nevus.
It is a rare presentation defined histologically. It should not be confused with small cell carcinoma or Merkel cell carcinoma: cellular appearance may require differential diagnosis, but the tumours have different origins.
Why it needs careful microscopic assessment
Descriptions include compact nests of cells with scant cytoplasm and dark nuclei, sometimes associated with an epidermal melanoma-in-situ component. Resemblance of the dermal component to a nevus can be misleading, especially in partial samples.
Architecture, atypia, maturation and relationships between components must be assessed together. Melanocytic markers may support diagnosis, but their distribution can vary within the tumour. Comparison with other small-cell neoplasms requires a panel selected by the pathologist.
Published series are limited. Age, sex or site patterns observed in a few patients do not become exclusion criteria. Expert review may help when the report remains uncertain.
From diagnosis to care
A suspicious lesion is assessed clinically and sampled when indicated; self-examination cannot determine cellular size. After diagnosis, site, Breslow thickness, ulceration, margins and spread guide decisions.
Management follows melanoma principles appropriate to the case, with surgery for localised disease and additional investigations or treatment when needed. There is no separate standard therapy selected solely because the cells are small.
Prognosis cannot be inferred from the name. Ask whether diagnosis is definitive, what the stage is and whether further sampling or slide review is needed. Follow-up addresses the disease actually documented.
Sources and update
- NCI — Melanoma Treatment (PDQ)
- Blessing et al. — Small cell malignant melanoma (2000)
- Lowe — Metastatic melanoma and rare melanoma variants (2023)
Editorial revision: 17 October 2026. This information does not replace medical assessment. For very rare variants, some evidence comes from small series or case reports.